# Cetuximab Therapeutic Drug Monitoring in Squamous Cell Carcinoma Head and Neck Cancer Patients: Determination of the Predictive Value Exposure Levels Through a Single Arm Multicentric Study

> **NCT04218136** · — · UNKNOWN · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 122 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **BIOLOGICAL:** Blood samples

## Key facts

- **NCT ID:** NCT04218136
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-26
- **Primary completion:** 2022-04-28
- **Final completion:** 2022-04-28
- **Target enrollment:** 122 (ESTIMATED)
- **Last updated:** 2020-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04218136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04218136, "Cetuximab Therapeutic Drug Monitoring in Squamous Cell Carcinoma Head and Neck Cancer Patients: Determination of the Predictive Value Exposure Levels Through a Single Arm Multicentric Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04218136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*